Palliative care improves quality of life in cancer patients receiving bone marrow transplants

Study is first to assess palliative care for patients receiving a curative treatment, decease impact on family caregivers

Integrating palliative care into the treatment of patients undergoing hematopoietic stem cell transplantation (HCT) – commonly known as bone marrow transplantation – for cancers like leukemia and lymphoma can improve their quality of life, click relieve symptoms associated with the procedure, order and reduce depression and anxiety, not only during the three- to four-week hospitalization required for the procedure but also several months later. In their paper published in the Nov. 22/29 issue of JAMA, the research team from Massachusetts General Hospital (MGH) also reports that caregivers of patients receiving palliative care experienced less depression and were better at coping with the stress associated with the illness of their family member or friend.

Read Full Article Here >>